Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

6.84USD
13 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.84
Open
$6.76
Day's High
$6.76
Day's Low
$6.76
Volume
114
Avg. Vol
21,387
52-wk High
$19.00
52-wk Low
$6.49

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.66 -0.599
Jun '18 0.46 -0.693
Mar '18 1.15 -0.741
FY 2017 Dec '17 0.99 -1.028
Sep '17 0.60 -0.869
Jun '17 0.25 -0.872
Mar '17 0.14 -0.513
FY 2016 Dec '16 0.34 -0.600
Sep '16 0.00 -0.533
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.80 1.60 0.00 --
Quarter Ending Mar-19 2 1.00 2.00 0.00 --
Year Ending Dec-18 6 3.07 3.80 2.27 5.00
Year Ending Dec-19 6 9.65 18.60 0.00 7.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.75 -0.61 -0.96 -3.03
Quarter Ending Mar-19 3 -0.80 -0.70 -0.91 --
Year Ending Dec-18 6 -2.81 -2.62 -3.01 -5.65
Year Ending Dec-19 6 -3.35 -2.59 -4.08 -10.11
LT Growth Rate (%) 1 40.40 40.40 40.40 0.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.58 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) -- 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions -- 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) -- 3.44 3.10
LT Debt to Equity (MRQ) -- 18.69 11.49
Total Debt to Equity (MRQ) -- 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -- -185.00 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -- -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -- -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,649,006 873,053,182
Net Income/Employee (TTM) -- 653,334 103,483,965
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) -- 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -- 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -- 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37

Performance for Spero Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 98
13 Week -- -- -- 94
26 Week -- -- -- 98
52 Week -- -- -- 68
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.84%
# of Holders: 83
Total Shares Held: 10,883,097
3 Mo. Net Change: 2,614,656
# New Positions: 15
# Closed Positions: 5
# Increased Positions: 51
# Reduced Positions: 13
# Net Buyers: 38
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.